Effectiveness of Automated Treatment Planning for Left-sided Breast in Flattening Filter-free Photon Beams

自动治疗计划在左侧乳腺平坦化无滤器光子束中的有效性

阅读:1

Abstract

PURPOSE: Electronic compensator is a time-consuming technique for breast cancer radiation treatment planning, consequently, this presents challenges for the development of automated treatment planning for the treatment plan. Thus, this study aimed to investigate the use of automated treatment planning software for the left breast. SUBJECTS AND METHODS: Thirty-eight patients with left-sided breast cancer without locoregional nodes were treated with a prescribed dose of 42.4 Gy in 16 fractions. Treatment planning was performed using electronic compensators. In addition, automated treatment planning techniques were utilized, which involved automated plan generation. This facilitated the comparison of dosimetric parameters: target volume (D(max), homogeneity index [HI], and conformity index [CI]), organs at risk, plan parameters, and quality assurance. RESULTS: The automated treatment planning exerted lower D(max) of PTV_Eval compared to electronic compensator techniques, that is, 43.4 ± 1.1 Gy and 43.9 ± 1.1 Gy, respectively (P < 0.05). Similarly, the HI of automated treatment planning was lower than other techniques, 0.10 ± 0.04 and 0.08 ± 0.03, respectively (P < 0.05). However, there were no significant differences in the CI or organs at risk between the two techniques (P = 0.11). In plan parameters, automated treatment planning required lower monitor units compared to the electronic compensator techniques, i.e., 534.3 ± 47.4 and 724.5 ± 117.9, respectively (P < 0.05). Furthermore, the automated treatment planning significantly reduced treatment time compared to electronic compensator techniques, that is, 2.3 ± 0.5 and 41.8 ± 15.1 min, respectively (P < 0.05). CONCLUSIONS: Automated treatment planning improved the treatment plan homogeneity, reduced hotspots, enhanced treatment planning efficiency, and reduced treatment planning time and doses comparable to those of normal organs.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。